Clonidine is an imidazole derivate that acts as an agonist of alpha-2 adrenoceptors. This activity is useful for the treatment of hypertension, severe pain, and ADHD.
Clonidine was granted FDA approval on 3 September 1974.
Clonidine tablets and transdermal systems are indicated for the treatment of hypertension alone or in combination with other medications. A clonidine injection is indicated for use with opiates in the treatment of severe cancer pain where opiates alone are insufficient. An extended release tablet of clonidine is indicated for the treatment of ADHD either alo...
Deventer Hospital, Deventer, Overijssel, Netherlands
Critical Care Unit, Hopital Desgenettes, Lyon, France
Rambam Health Care Campus, Haifa, Israel
Columbia University Medical Center, New York, New York, United States
Cooperative University, Envigado, Antioquia, Colombia
IMIP, Recife, Pernambuco, Brazil
University of Kentucky Medical Center, Lexington, Kentucky, United States
Federal University of Sao Paulo, Sao Paulo, Brazil
University of São Paulo General Hospital, São Paulo, Brazil
National institut of Cardiology, Rio de Janeiro, RJ, Brazil
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.